NVS
Novartis AG Sponsored ADR · NYSE
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website novartis.com
- Employees(FY) 101703
- ISIN US66987V1098
Performance
+2.89%
1W
+2.75%
1M
+11.37%
3M
+5.65%
6M
+11.94%
YTD
+14.84%
1Y
Profile
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company offers prescription medicines for patients and physicians. It focuses on therapeutic areas, such as cardiovascular, renal and metabolic, immunology, neuroscience, and oncology, as well as ophthalmology and hematology. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.
Investment Analysis Report: Novartis AG (NVS)
Overview
Novartis AG (NVS) is a leading pharmaceutical company in the Health Technology sector, specializing in Major Pharmaceuticals. With a market capitalization of $225.58 billion, Novartis has a strong presence in the industry. In this report, we will conduct a comprehensive analysis of Novartis ...
Technical Analysis of NVS 2024-07-18
Overview
Analyzing the recent technical indicators for Novartis AG (NVS) provides a comprehensive view of the stock's potential price movements in the coming days. The data from the last five trading days reveals a mix of bullish and bearish signals, indicating a complex market environment. By examining trend, momentum, volatility, and volume in...
Recent News & Updates
- 2024-07-25 04:19
Dren Bio and Novartis link on bispecific antibodies for cancer(Pharmaceutical Technology)
- 2024-07-24 10:26
- 2024-07-24 07:24
- 2024-07-23 07:05
- 2024-07-22 09:00
- 2024-07-19 19:47
- 2024-07-19 13:47
Analyst Report: Novartis AG(Argus Research)
- 2024-07-19 13:32
Market Update: NVS, AXP, DPZ, EFX, MTB, CRWD(Argus Research)
- 2024-07-19 09:56
- 2024-07-19 09:26
- 2024-07-19 06:57
- 2024-07-18 22:15
Novartis Falls Despite Earnings Beat, Guidance Raise(Investopedia)
- 2024-07-18 19:55
Novartis Reports Nearly 40% Margin In Q2; Shares Slide(Yahoo Finance)
- 2024-07-18 16:45
Novartis Ag (NVS) Q2 2024 Earnings Call Transcript(Motley Fool)
- 2024-07-18 14:15
- 2024-07-18 13:52
- 2024-07-18 12:36
Analyst Report: Novartis AG(Morningstar Research)
- 2024-07-18 12:12
- 2024-07-18 11:51
Novartis Dives After Handing Amgen, Bristol — And Their Rivals — A Key Victory(Investor's Business Daily)
- 2024-07-18 10:15
Novartis Falls Despite Earnings Beat, Guidance Raise(Investopedia)
- 2024-07-18 09:54
Novartis raises 2024 profit guidance, stock slipping though(Yahoo Finance Video)
- 2024-07-18 09:30
- 2024-07-18 09:06
- 2024-07-18 08:22
- 2024-07-18 06:53
Novartis reports 43% increase in net income in Q2 2024(Pharmaceutical Technology)
- 2024-07-18 06:31
- 2024-07-18 05:13
Novartis: Q2 Earnings Snapshot(Associated Press Finance)
- 2024-07-18 04:59
2 Magnificent Stocks to Buy With $500(Motley Fool)
- 2024-07-18 03:35
- 2024-07-18 02:23
Novartis raises FY profit guidance after strong quarter(Investing.com)
Page 1 of 10
previousnext